Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).
Clinical trial NCT01282593 · COMPLETED
Trial details
- NCT number
- NCT01282593
- Sponsor
- Rennes University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2018-10-11
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.